FXAIX
Price
$231.56
Change
+$1.22 (+0.53%)
Updated
Oct 17 closing price
Net Assets
722.95B
LZUOX
Price
$17.98
Change
+$0.05 (+0.28%)
Updated
Oct 17 closing price
Net Assets
80.71M
Interact to see
Advertisement

FXAIX vs LZUOX

Header iconFXAIX vs LZUOX Comparison
Open Charts FXAIX vs LZUOXBanner chart's image
Fidelity 500 Index
Price$231.56
Change+$1.22 (+0.53%)
VolumeN/A
Net Assets722.95B
Lazard US Equity Focus Open
Price$17.98
Change+$0.05 (+0.28%)
VolumeN/A
Net Assets80.71M
FXAIX vs LZUOX Comparison Chart in %
View a ticker or compare two or three
VS
FXAIX vs. LZUOX commentary
Oct 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FXAIX is a Hold and LZUOX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FXAIX has more cash in the bank: 723B vs. LZUOX (80.7M). FXAIX pays higher dividends than LZUOX: FXAIX (1.12) vs LZUOX (0.47). FXAIX was incepted earlier than LZUOX: FXAIX (14 years) vs LZUOX (21 years). LZUOX (1.31) is less costly to investors than FXAIX (0.01). LZUOX is a more actively managed with annual turnover of: 22.00 vs. FXAIX (3.00). FXAIX has a lower initial minimum investment than LZUOX: FXAIX (0) vs LZUOX (2500). FXAIX annual gain was more profitable for investors over the last year : 14.93 vs. LZUOX (1.58). FXAIX return over 5 years is better than : 104.83 vs. LZUOX (43.25).
FXAIXLZUOXFXAIX / LZUOX
Total Expense Ratio0.010.952%
Annual Report Gross Expense Ratio0.011.311%
Fund Existence14 years21 years-
Gain YTD13.8328.444164%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets723B80.7M895,911%
Annual Yield % from dividends1.120.47241%
Returns for 1 year14.931.58942%
Returns for 3 years86.1840.70212%
Returns for 5 years104.8343.25242%
Returns for 10 years259.6256.56459%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INTI0.05N/A
N/A
Inhibitor Therapeutics Inc.
RSMDF24.76N/A
N/A
Resmed Inc.
KOBNF29.57N/A
N/A
Kobe Bussan Co., Ltd.
LNZNF29.25N/A
N/A
Lenzing AG
PLMJF11.29N/A
N/A
Plum Acquisition Corp. III